Anchor Capital Advisors LLC cut its stake in Colgate-Palmolive (NYSE:CL) by 1.6% in the 4th quarter, Holdings Channel reports. The firm owned 94,380 shares of the company’s stock after selling 1,522 shares during the quarter. Anchor Capital Advisors LLC’s holdings in Colgate-Palmolive were worth $5,617,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of CL. Dearborn Partners LLC increased its position in shares of Colgate-Palmolive by 4.7% during the fourth quarter. Dearborn Partners LLC now owns 15,746 shares of the company’s stock valued at $937,000 after acquiring an additional 701 shares during the last quarter. Patriot Financial Group Insurance Agency LLC increased its position in shares of Colgate-Palmolive by 329.0% during the fourth quarter. Patriot Financial Group Insurance Agency LLC now owns 901 shares of the company’s stock valued at $54,000 after acquiring an additional 691 shares during the last quarter. Duff & Phelps Investment Management Co. increased its position in shares of Colgate-Palmolive by 4.8% during the fourth quarter. Duff & Phelps Investment Management Co. now owns 9,460 shares of the company’s stock valued at $563,000 after acquiring an additional 430 shares during the last quarter. Pinnacle Financial Partners Inc. increased its position in shares of Colgate-Palmolive by 1.1% during the fourth quarter. Pinnacle Financial Partners Inc. now owns 29,534 shares of the company’s stock valued at $1,758,000 after acquiring an additional 315 shares during the last quarter. Finally, Yacktman Asset Management LP increased its position in shares of Colgate-Palmolive by 0.9% during the fourth quarter. Yacktman Asset Management LP now owns 1,256,600 shares of the company’s stock valued at $74,793,000 after acquiring an additional 11,300 shares during the last quarter. 75.21% of the stock is owned by hedge funds and other institutional investors.
In other Colgate-Palmolive news, Director John T. Cahill sold 5,780 shares of the stock in a transaction on Thursday, January 31st. The stock was sold at an average price of $64.46, for a total transaction of $372,578.80. Following the completion of the transaction, the director now directly owns 27,820 shares of the company’s stock, valued at $1,793,277.20. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.02% of the stock is currently owned by corporate insiders.
Shares of NYSE CL opened at $65.94 on Thursday. Colgate-Palmolive has a 1-year low of $57.41 and a 1-year high of $72.61. The firm has a market cap of $56.97 billion, a price-to-earnings ratio of 22.20, a PEG ratio of 4.24 and a beta of 0.78.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 25th. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a return on equity of 25,268.29% and a net margin of 15.44%. The business had revenue of $3.81 billion during the quarter, compared to analyst estimates of $3.78 billion. During the same period in the prior year, the company earned $0.75 earnings per share. Colgate-Palmolive’s revenue was down 2.1% compared to the same quarter last year. On average, equities research analysts predict that Colgate-Palmolive will post 2.83 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 15th. Shareholders of record on Wednesday, January 23rd will be issued a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a yield of 2.55%. The ex-dividend date of this dividend is Tuesday, January 22nd. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.57%.
CL has been the subject of a number of research analyst reports. Wells Fargo & Co decreased their price target on Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating for the company in a research report on Wednesday, October 17th. UBS Group set a $71.00 price target on Colgate-Palmolive and gave the company a “buy” rating in a research report on Wednesday, October 17th. SunTrust Banks downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price target for the company from $80.00 to $65.00 in a research report on Friday, October 26th. JPMorgan Chase & Co. downgraded Colgate-Palmolive from a “neutral” rating to an “underweight” rating and decreased their price target for the company from $61.00 to $54.00 in a research report on Monday, October 29th. Finally, Citigroup decreased their price target on Colgate-Palmolive from $68.00 to $63.00 and set a “hold” rating for the company in a research report on Monday, October 29th. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and three have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $65.13.
ILLEGAL ACTIVITY WARNING: “Anchor Capital Advisors LLC Has $5.62 Million Stake in Colgate-Palmolive (CL)” was originally published by Enterprise Leader and is the property of of Enterprise Leader. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://theenterpriseleader.com/2019/02/14/anchor-capital-advisors-llc-has-5-62-million-stake-in-colgate-palmolive-cl.html.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Featured Article: How accurate is the Rule of 72?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.